These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25650304)

  • 1. Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: A systematic review and meta-analysis.
    Xia BW; Zhang YC; Wang J; Ding FH; He XD
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):458-68. PubMed ID: 25650304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
    Xu J; Li J; Chen J; Liu ZJ
    Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleot(s)ide analogues for hepatitis B virus-related hepatocellular carcinoma after curative treatment: a systematic review and meta-analysis.
    Sun P; Dong X; Cheng X; Hu Q; Zheng Q
    PLoS One; 2014; 9(7):e102761. PubMed ID: 25058587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis.
    Zhou HY; Luo Y; Chen WD; Gong GZ
    J Gastroenterol Hepatol; 2015 Jun; 30(6):977-83. PubMed ID: 25689418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.
    Zhang G; Yu X; Liu P; Huang X; Jiang X
    Dig Dis Sci; 2018 Dec; 63(12):3207-3219. PubMed ID: 30140982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study.
    Yin J; Li N; Han Y; Xue J; Deng Y; Shi J; Guo W; Zhang H; Wang H; Cheng S; Cao G
    J Clin Oncol; 2013 Oct; 31(29):3647-55. PubMed ID: 24002499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
    Hosaka T; Suzuki F; Kobayashi M; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    Liver Int; 2010 Nov; 30(10):1461-70. PubMed ID: 20840396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis.
    Yuan P; Chen P; Qian Y
    Can J Gastroenterol Hepatol; 2016; 2016():5234969. PubMed ID: 27446846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.
    Chong CC; Wong GL; Lai PB
    World J Gastroenterol; 2014 May; 20(20):6006-12. PubMed ID: 24876723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated lactate impairs the efficacy of antiviral treatment on post-hepatectomy survival for advanced stage hepatitis B virus - related hepatocellular carcinoma.
    Zhao J; Wang J; Chai S; Zhang Y; Zhang W
    Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):67-76. PubMed ID: 30219693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial.
    Huang G; Lau WY; Wang ZG; Pan ZY; Yuan SX; Shen F; Zhou WP; Wu MC
    Ann Surg; 2015 Jan; 261(1):56-66. PubMed ID: 25072444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials.
    Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ge YS
    Int J Cancer; 2011 Sep; 129(5):1254-64. PubMed ID: 21710498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy decreases recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection: a meta-analysis.
    Zhou Y; Zhang Z; Zhao Y; Wu L; Li B
    World J Surg; 2014 Sep; 38(9):2395-402. PubMed ID: 24791945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma.
    Ishikawa T
    World J Gastroenterol; 2013 Dec; 19(47):8861-6. PubMed ID: 24379608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C.
    Wei Q; Tian H; Luo HX; Zhang YC; Deng YN; Yao J; Li H; Chen GH; Yang Y
    Asian J Surg; 2017 Nov; 40(6):453-462. PubMed ID: 27321176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.
    Sohn W; Kang TW; Choi SK; Jung SH; Lee MW; Lim HK; Cho JY; Shim SG; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Rhim H; Paik YH
    Oncotarget; 2016 Jul; 7(30):47794-47807. PubMed ID: 27329596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
    Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S
    J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma.
    Huang S; Xia Y; Lei Z; Zou Q; Li J; Yang T; Wang K; Yan Z; Wan X; Shen F
    J Am Coll Surg; 2017 Mar; 224(3):283-293.e4. PubMed ID: 27923614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.